首页> Annals of oncology : official journal of the European Society for Medical Oncology> Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?

Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?

导出原文传递

翻译打印收藏纠错

第一作者： R,Font

第一单位： Biomedical Research Institute, Bellvitge, (IDIBELL) - L'Hospitalet de LLob, Barcelona.

作者： R,Font ^[1] ; J A,Espinas ^[1] ; L,Layos ^[2] ; M,Martinez Villacampa ^[3] ; J,Capdevila ^[4] ; M,Tobeña ^[5] ; A,Pisa ^[6] ; C,Pericay ^[7] ; C,Lezcano ^[8] ; E,Fort ^[9] ; I,Cardona ^[10] ; N,Berga ^[11] ; J,Solà ^[1] ; J M,Borras ^[12]

作者单位： Biomedical Research Institute, Bellvitge, (IDIBELL) - L'Hospitalet de LLob, Barcelona. ^[1] Medical Oncology Service, Catalan Institute of Oncology, ICO Badalona, Barcelona. ^[2] Medical Oncology Department, Catalan Institute of Oncology, ICO L'Hospitalet de LLob, Barcelona. ^[3] Medical Oncology Department, Hospital Vall d'Hebron, VHIO, Barcelona. ^[4] Medical Oncology Service, Hospital Santa Creu i Sant Pau, Barcelona. ^[5] Medical Oncology Service, Consorci Sanitari de Terrassa, Terrassa. ^[6] Medical Oncology Service, Hospital Parc Taulí, Sabadell, Barcelona. ^[7] Clinical Pharmacy Service, Hospital Germans Trias i Pujol, Badalona. ^[8] Clinical Pharmacy Service, ICO L'Hospitalet de LLob, Barcelona. ^[9] Clinical Pharmacy Unit, Hospital Vall d'Hebron, Barcelona. ^[10] Clinical Pharmacy Service, Hospital Sta. Creu i Sant Pau, Barcelona. ^[11] Biomedical Research Institute, Bellvitge, (IDIBELL) - L'Hospitalet de LLob, Barcelona.;Department of Clinical Sciences, Universitat of Barcelona, Barcelona, Spain. ^[12]

关键词 HAD adherence oral chemotherapy quality of life rectal cancer